(Q38446206)

English

Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells

scientific article published on 10 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

anaplastic thyroid cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Raktim Biswas

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Phil-Sang Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jeong Hwan Moon

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Seung-Ha Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jin-Chul Ahn

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

10 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Lasers in Medical Science

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

995-1007

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

https://scigraph.springernature.com/pub.10.1007/s10103-013-1452-9

0 references

Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Distant metastases from thyroid and parathyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photodynamic therapy for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photodynamic therapy for cancer: principles

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

How does photodynamic therapy work?

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permeabilization

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

The present and future role of photodynamic therapy in cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photodynamic therapy: a clinical reality in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

A review of progress in clinical photodynamic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

In vitro evaluation of Radachlorin sensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photodynamic therapy of early esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photosensitizer Radachlorin®: Skin cancer PDT phase II clinical trials.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

The resurgence of platinum-based cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Platinum-based chemotherapy in metastatic breast cancer: current status.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

The status of platinum anticancer drugs in the clinic and in clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Combination with genistein enhances the efficacy of photodynamic therapy against human anaplastic thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Drug combination studies and their synergy quantification using the Chou-Talalay method

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of r

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Unusual adverse reaction in a patient sensitized with Photosan 3.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT.

1 reference

https://api.crossref.org/works/10.1007%2FS10103-013-1452-9

21 January 2018

Analysis of cell cycle by flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaplastic thyroid cancer therapy: dream or reality?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic effects of Radachlorin on cervical cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24114422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10103-013-1452-9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38446206&oldid=1760151908"